Show
Sort by
-
Nebulized antibiotics for ventilator-associated pneumonia : methodological framework for future multicenter randomized controlled trials
-
- Journal Article
- A1
- open access
Core outcomes set for trials in people with coronavirus disease 2019
-
- Journal Article
- A1
- open access
Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future hospital-acquired/ventilator-associated bacterial pneumonia clinical trials
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
-
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
-
Prevalence and etiology of community-acquired pneumonia in immunocompromised patients
-
- Journal Article
- A1
- open access
Antivirals for influenza-Like Illness? : a randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC⁴E) : the ALIC⁴E protocol
-
Year in review in Intensive Care Medicine 2014, III: severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics
-
Year in review in Intensive Care Medicine 2014, II: ARDS, airway management, ventilation, adjuvants in sepsis, hepatic failure, symptoms assessment and management, palliative care and support for families, prognostication, organ donation, outcome, organisation and research methodology